We are live on
!
Find out more
DA
DSC Advisors Portfolio holdings
AUM
$11M
1-Year Est. Return
5.88%
This Fund
S&P 500
This Quarter
Est. Return
-27.79%
1 Year Est. Return
+5.88%
3 Year Est. Return
+3.18%
5 Year Est. Return
+39.43%
10 Year Est. Return
+114.64%
AUM
$102M
AUM Growth
-$106M
(-51%)
Cap. Flow
-$67.2M
Cap. Flow
% of AUM
-65.66%
Top 10 Holdings %
Top 10 Hldgs %
89.07%
Holding
89
New
5
Increased
1
Reduced
24
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HCA Healthcare
HCA
|
+$11.2M |
| 2 |
VYNE Therapeutics
VYNE
|
+$9.04M |
| 3 |
ACEL.WS
Accel Entertainment Inc Warrant
ACEL.WS
|
+$54.4K |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$13.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$11.7M |
| 2 |
Delta Air Lines
DAL
|
+$11.7M |
| 3 |
Cencora
COR
|
+$11.4M |
| 4 |
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
|
+$11.2M |
| 5 |
DaVita
DVA
|
+$9.75M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.23% |
| 2 | Financials | 17.42% |
| 3 | Communication Services | 13.25% |
| 4 | Consumer Discretionary | 4.15% |
| 5 | Technology | 3.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
| $25.8M | 25.17% |
+100,000
| New | +$30.5M |
|
2
Alphabet (Google) Class C
GOOG
$4.22T
| $12M | 11.7% |
206,000
-24,000
| -10% | -$1.63M |
|
|
ATH
3
DELISTED
Athene Holding Ltd. Class A Common Shares
ATH
| $8.27M | 8.07% |
333,000
-220,921
| -40% | -$8.79M |
|
4
Morgan Stanley
MS
$339B
| $8.24M | 8.05% |
242,337
-92,509
| -28% | -$4.36M |
|
5
CVS Health
CVS
$137B
| $7.83M | 7.65% |
132,018
-46,773
| -26% | -$3.12M |
|
|
6
HCA Healthcare
HCA
$82.3B
| $7.74M | 7.56% |
+86,160
| New | +$11.2M |
|
|
7
CALL
HCA Healthcare
HCA
$82.3B
| $7.73M | 7.55% |
+86,000
| New | +$11.1M |
|
|
8
VYNE Therapeutics
VYNE
$25.4M
| $5.56M | 5.43% |
+28,830
| New | +$9.04M |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals
ALXN
| $4.04M | 3.95% |
45,000
-23,500
| -34% | -$2.31M |
|
10
Accel Entertainment
ACEL
$989M
| $4.04M | 3.94% |
538,200
-111,800
| -17% | -$1.23M |
|
11
Bristol-Myers Squibb
BMY
$124B
| $2.81M | 2.74% |
50,320
-20,919
| -29% | -$1.28M |
|
12
Zevra Therapeutics
ZVRA
$755M
| $922K | 0.9% |
255,995
| – | – |
|
|
13
CALL
CVS Health
CVS
$137B
| $653K | 0.64% |
11,000
-50,000
| -82% | -$3.34M |
|
14
Microsoft
MSFT
$2.93T
| $635K | 0.62% |
4,029
-10,289
| -72% | -$1.69M |
|
|
15
Alphabet (Google) Class A
GOOGL
$4.23T
| $565K | 0.55% |
9,720
-23,520
| -71% | -$1.59M |
|
16
Netflix
NFLX
$290B
| $516K | 0.5% |
13,730
-28,260
| -67% | -$1,000K |
|
17
Meta Platforms (Facebook)
META
$1.64T
| $508K | 0.5% |
3,044
-6,297
| -67% | -$1.23M |
|
18
Visa
V
$682B
| $483K | 0.47% |
2,998
-6,319
| -68% | -$1.19M |
|
19
Adobe
ADBE
$94.3B
| $470K | 0.46% |
1,477
-3,431
| -70% | -$1.17M |
|
20
Mastercard
MA
$480B
| $445K | 0.43% |
1,844
-3,909
| -68% | -$1.16M |
|
21
Salesforce
CRM
$140B
| $426K | 0.42% |
2,961
-5,642
| -66% | -$967K |
|
22
Accenture
ACN
$87.9B
| $420K | 0.41% |
2,570
-4,756
| -65% | -$916K |
|
23
PayPal
PYPL
$49.9B
| $401K | 0.39% |
4,185
-7,744
| -65% | -$855K |
|
24
Oracle
ORCL
$364B
| $394K | 0.38% |
8,160
-15,098
| -65% | -$779K |
|
25
IBM
IBM
$200B
| $376K | 0.37% |
3,544
-6,557
| -65% | -$829K |
|
Similar funds
RJTCONH
HSC
BGC
ACM
AG
RVM
JDR
KM
DSC Advisors's Q1 2020 Portfolio in Review
As of Q1 2020, DSC Advisors held 89 positions worth $102M, down 51% from $209M the previous quarter. Its ten largest holdings account for 89% of the portfolio.
DSC Advisors withdrew a net $67.2M in Q1 2020, closing 58 positions and reducing 24 holdings. Its most notable exit was Zimmer Biomet, an estimated $11.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 35% a quarter earlier, followed by Financials and Communication Services.
Against the trend, DSC Advisors opened a new position in HCA Healthcare worth $7.74M.
- DSC Advisors's largest Q1 2020 buy was HCA Healthcare: 86,160 shares worth $7.74M.
- DSC Advisors added most to Accel Entertainment Inc Warrant in Q1 2020, an estimated $54.4K increase.
- DSC Advisors's biggest Q1 2020 reduction was Athene Holding Ltd. Class A Common Shares, cutting an estimated $8.79M.
- DSC Advisors fully exited Zimmer Biomet in Q1 2020, selling an estimated $11.7M.
- DSC Advisors's ten largest holdings make up 89% of its $102M portfolio in Q1 2020.
- DSC Advisors opened 5 new positions and closed 58 in Q1 2020.
- DSC Advisors's portfolio value fell 51% quarter-over-quarter to $102M.
Based on DSC Advisors's 13F filing for Q1 2020, filed 15 May 2020.